Onward Medical NV (FRA:63E) Change In Receivables : €0.23 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV Change In Receivables?

Onward Medical NV's change in receivables for the quarter that ended in Jun. 2024 was €-0.83 Mil. It means Onward Medical NV's Accounts Receivable increased by €0.83 Mil from Dec. 2023 to Jun. 2024 .

Onward Medical NV's change in receivables for the fiscal year that ended in Dec. 2023 was €0.49 Mil. It means Onward Medical NV's Accounts Receivable declined by €0.49 Mil from Dec. 2022 to Dec. 2023 .

Onward Medical NV's Accounts Receivable for the quarter that ended in Jun. 2024 was €0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Onward Medical NV's liquidation value for the six months ended in Jun. 2024 was €3.55 Mil.

Onward Medical NV Change In Receivables Historical Data

The historical data trend for Onward Medical NV's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV Change In Receivables Chart

Onward Medical NV Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-0.02

-0.22

-2.36

0.14

0.49

Onward Medical NV Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Change In Receivables	Get a 7-Day Free Trial						-0.55	0.69	-0.57	1.06	-0.83

Onward Medical NV Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.23 Mil.

Onward Medical NV (FRA:63E) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Onward Medical NV's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Onward Medical NV's accounts receivable are only considered to be worth 75% of book value:

Onward Medical NV's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	32.053	-	28.506	+	0.75 * 0	+	0.5 * 0
=	3.55

Onward Medical NV Change In Receivables Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Onward Medical NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (FRA:63E) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

63E:Germany ONWD:Belgium

Address

High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE

Website

https://www.onwd.com

Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injuries. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United States and four European markets: Germany, France, the UK, and the Netherlands to create a customer base.

Onward Medical NV Headlines

No Headlines